These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 16335673

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
    Wieczór R, Gadomska G, Góralczyk B, Stankowska K, Budzyński J, Fabisiak J, Suppan K, Pulkowski G, Rość D.
    Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
    [Abstract] [Full Text] [Related]

  • 6. Overweight and obesity versus concentrations of VEGF-A, sVEGFR-1, and sVEGFR-2 in plasma of patients with lower limb chronic ischemia.
    Wieczór R, Wieczór AM, Gadomska G, Stankowska K, Fabisiak J, Suppan K, Pulkowski G, Budzyński J, Rość D.
    J Zhejiang Univ Sci B; 2015 Dec; 17(11):842-849. PubMed ID: 27819131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A, Robak T, Wrzesień-Kuś A, Krawczyńska A, Lech-Marańda E, Urbańska-Ryś H.
    Eur Cytokine Netw; 2003 Dec; 14(3):149-53. PubMed ID: 14656688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 15. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
    Kikuchi S, Obata Y, Yagyu K, Lin Y, Nakajima T, Kobayashi O, Kikuichi M, Ushijima R, Kurosawa M, Ueda J.
    Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
    [Abstract] [Full Text] [Related]

  • 16. Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer.
    Perroud HA, Rico MJ, Alasino CM, Pezzotto SM, Rozados VR, Scharovsky OG.
    Indian J Cancer; 2013 Apr; 50(2):115-21. PubMed ID: 23979202
    [Abstract] [Full Text] [Related]

  • 17. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
    Sertoglu E, Omma A, Yucel C, Colak S, Sandıkcı SC, Ozgurtas T.
    Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
    [Abstract] [Full Text] [Related]

  • 18. Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients.
    Ustuner Z, Saip P, Yasasever V, Vural B, Yazar A, Bal C, Ozturk B, Ozbek U, Topuz E.
    Med Oncol; 2008 Oct; 25(4):394-9. PubMed ID: 18317954
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Usefulness of VEGF, MMP-2, MMP-3 and TIMP-2 serum level evaluation in patients with adrenal tumours.
    Kolomecki K, Stepien H, Bartos M, Kuzdak K.
    Endocr Regul; 2001 Mar; 35(1):9-16. PubMed ID: 11308991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.